The German Research Foundation (DFG) is funding the Research Unit 5042 "miTarget: The microbiome as a therapeutic target in chronic inflammatory bowel…
In a clinical phase 2 study, a research team involving Kiel has demonstrated the effectiveness of an IL-23 blocking treatment against psoriasis, which…